Cover Image
市場調查報告書

全球介入神經放射學市場預測

Global Interventional Neurology Market Outlook to 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 349900
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
全球介入神經放射學市場預測 Global Interventional Neurology Market Outlook to 2020
出版日期: 2016年01月01日 內容資訊: 英文 48 Pages
簡介

全球介入神經放射學市場,2014年達到了16億美元規模。產業達成著急速成長。

本報告提供全球介入神經放射學市場相關調查分析,市場現況與展望,主要推動因素與課題,趨勢與發展,競爭情形等系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 介入神經放射學:簡介

  • 介入神經放射學相關的技術

第4章 推動因素與課題

  • 推動因素
  • 課題

第5章 介入神經放射學市場概要

第6章 市場區隔

  • 各產品
  • 各地區

第7章 趨勢與發展

  • 對麻痺患者有益
  • 新產品回顧

第8章 競爭評估

  • 主要企業的市場佔有率
  • 企業簡介
    • Stryker Corporation
    • Covidien (Medtronic Inc.完全擁有的子公司)
    • Johnson & Johnson
    • Terumo Inc

第9章 建議

圖表

目錄

Due to changing lifestyle and unhealthy dietary habits, a number of chronic diseases are affecting the masses across the globe. Some of the prominent disorders like obesity, diabetes, cardiovascular diseases and neurological ailments directly or indirectly lead to decline in the productivity of the working population, ultimately hampering the profitability of businesses. Therefore, increasing epidemiology of the diseases require effective treatment options. Although, conventional treatments have been successfully serving the patients for most of the diseases, yet these causes immense mental and physical pressure both on the part of surgeons and patients. Moreover, increasing healthcare expenditures along with changing consumers' needs is generating significant demand for additional therapies. One such popular technique is interventional neurology. This technique provides a cost effective alternative for traditional neurosurgery.

According to RNCOS new release, “Global Interventional Neurology Market Outlook to 2020”, the industry is expanding at a fast pace. The study has been done comprehensively including factors affecting growth, latest innovations, market segmentation and competitive landscape.

The global market for interventional neurology was worth US$ 1.6 Billion in 2014. Embolyzing products (coils and systems) accounted for the largest share of the market in 2014, followed by Catheters. The report provides the current market and future forecast of different interventional neurology products. Moreover, the report also includes the detailed analysis of the report based on geography. According to the report, developed markets including those of the US, Germany, France, Italy, and the UK holds the major share in the market. However, the Asia Pacific region is slated to witness the highest growth in the forecasted period. The growth of the Asia Pacific market is driven by improving healthcare facilities and increasing government investment in this region.

Further, prudent analysis has been done on the competitor's part, where three major players grab 70% of the global market by revenue. Stryker, Covidien, Terumo, and Johnson & Johnson are the key influencers with their products covering all the categories. New releases, collaborations and extending distribution networks are few important factors for their dominance.

Towards the end, RNCOS has suggested some recommendations to boost the interventional neurology market in the coming future. On the whole, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the neurovascular devices industry.

Table of Contents

1. Analyst View

2. Research Methodology

3. Interventional Neurology - An Introduction

  • 3.1. Techniques Involved in Interventional Neurology
    • 3.1.1. Neurothrombectomy
    • 3.1.2. Cerebral Angiography
    • 3.1.3. Stenting technique
    • 3.1.4. Coiling Procedure

4. Drivers & Challenges

  • 4.1. Drivers
    • 4.1.1. Rising Healthcare Expenditure
    • 4.1.2. Growing Geriatric Population
    • 4.1.3. Rapidly Rising Cerebrovascular Diseases
    • 4.1.4. Advantages Over Conventional Surgery
  • 4.2. Challenges
    • 4.2.1. High Cost of Interventional Neurovascular Devices
    • 4.2.2. Low Awareness

5. Interventional Neurology Market Overview

6. Market Segmentation

  • 6.1. By Products
  • 6.2. By Geography

7. Trends & Developments

  • 7.1. Interventional Neurology Benefiting Paralytic Patients
  • 7.2. Market Rewarded with New Launches

8. Competitive Assessment

  • 8.1. Market Share of Key Players
  • 8.2. Company Profiles
    • 8.2.1. Stryker Corporation
    • 8.2.2. Covidien (A Wholly Owned Subsidiary of Medtronic Inc.)
    • 8.2.3. Johnson & Johnson
    • 8.2.4. Terumo Inc

9. Recommendations

List of Figures:

  • Figure 5-1: Global - Interventional Neurology Market (Billion US$), 2014-2020
  • Figure 6-1: Global - Interventional Neurology Market by Products (%), 2014
  • Figure 6-2: Global - Embolizing Products Market for Interventional Neurology (Million US$), 2014 & 2020
  • Figure 6-3: Global - Cathetors Market for Interventional Neurology (Million US$), 2014 & 2020
  • Figure 6-4: Global - Stents Market for Interventional Neurology (Million US$), 2014 & 2020
  • Figure 6-5: Global - Other Instruments Market for Interventional Neurology (Million US$), 2014 & 2020
  • Figure 6-6: Global - Interventional Neurology Market by Geography (%), 2014
  • Figure 6-7: US - Interventional Neurology Market (Million US$), 2014 & 2020
  • Figure 6-8: Europe - Interventional Neurology Market (Million US$), 2014 & 2020
  • Figure 6-9: Asia-Pacific - Interventional Neurology Market (Million US$), 2014 & 2020
  • Figure 6-10: RoW - Interventional Neurology Market (Million US$), 2014 & 2020
  • Figure 8-1: Share of Major Players in Interventional Neurology Market (%), 2014
  • Figure 8-2: Stryker - Breakup of Revenue by Geography (%), 2014
  • Figure 8-3: Covidien - Breakup of Revenue by Geography (%), 2014
  • Figure 8-4: J&J - Breakup of Revenue by Geography (%), 2014
  • Figure 8-5: Terumo Inc - Breakup of Cardiac & Vascular Segment Revenue by Geography (%), 2014

List of Tables:

  • Table 7-1: New Devices Launched in Global Interventional Neurology Market, 2013-2015
  • Table 8-1: Stryker - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 8-2: Covidien - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 8-3: J&J - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 8-4: Terumo Inc - Revenue by Business Segments (Billion US$), 2013 & 2014
Back to Top